Startseite Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt
Artikel Open Access

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt

  • Weixi Xue ORCID logo EMAIL logo
Veröffentlicht/Copyright: 27. März 2024

Abstract

C16H18ClN2OPt, monoclinic, P21/c (no. 14), a = 7.2964(19) Å, b = 11.010(3) Å, c = 20.283(5) Å, β = 92.582(3)°, V = 1627.7(7) Å3, Z = 4, R gt(F) = 0.0433, wR ref(F 2) = 0.1157, T = 296.15 K.

CCDC no.: 2280555

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.06 × 0.06 × 0.06 mm
Wavelength: MoKα radiation (0.71073 Å)
μ: 8.78 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θ max, completeness: 25.0°, >99 %
N(hkl)measured, N(hkl)unique, R int: 10,927, 2868, 0.063
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 2568
N(param)refined: 192
Programs: Bruker [1], Olex2 [2], Shelx [3, 4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
Pt1 0.74376 (4) 0.65376 (2) 0.36935 (2) 0.02980 (16)
Cl1 0.8282 (3) 0.6232 (2) 0.25627 (10) 0.0477 (5)
O1 0.5171 (13) 0.9677 (6) 0.5810 (3) 0.081 (2)
N1 0.8114 (7) 0.4821 (5) 0.3980 (3) 0.0308 (13)
N2 0.6623 (10) 0.8304 (5) 0.3459 (3) 0.0377 (16)
C1 0.8693 (11) 0.3940 (8) 0.3583 (4) 0.0402 (19)
H1 0.882036 0.411564 0.313871 0.048*
C2 0.9106 (11) 0.2790 (7) 0.3806 (5) 0.048 (2)
H2 0.952034 0.219857 0.352064 0.058*
C3 0.8890 (10) 0.2535 (8) 0.4464 (5) 0.051 (2)
H3 0.914455 0.176185 0.462932 0.062*
C4 0.8302 (11) 0.3423 (6) 0.4870 (5) 0.042 (2)
H4 0.817411 0.325529 0.531462 0.050*
C5 0.7891 (10) 0.4568 (6) 0.4632 (3) 0.0326 (16)
C6 0.7233 (10) 0.5583 (6) 0.5014 (4) 0.0319 (16)
C7 0.6899 (10) 0.6696 (6) 0.4633 (4) 0.0265 (16)
C8 0.6298 (9) 0.7678 (7) 0.4988 (3) 0.0332 (16)
H8 0.606757 0.840881 0.476980 0.040*
C9 0.6022 (9) 0.7610 (8) 0.5672 (3) 0.0354 (17)
C10 0.6326 (13) 0.6547 (7) 0.6009 (4) 0.046 (2)
H10 0.611917 0.650088 0.645732 0.055*
C11 0.6954 (11) 0.5528 (7) 0.5671 (3) 0.0351 (17)
H11 0.718116 0.480732 0.589875 0.042*
C12 0.5435 (13) 0.8689 (9) 0.6039 (4) 0.049 (2)
H12 0.525366 0.859135 0.648640 0.059*
C13 0.5057 (15) 0.8306 (8) 0.2933 (4) 0.059 (3)
H13A 0.466094 0.913665 0.285375 0.071*
H13B 0.550881 0.799187 0.252397 0.071*
C14 0.3443 (13) 0.7563 (13) 0.3122 (5) 0.084 (3)
H14A 0.243297 0.770409 0.281169 0.126*
H14B 0.309812 0.779169 0.355596 0.126*
H14C 0.376430 0.671773 0.311929 0.126*
C15 0.8142 (16) 0.9096 (9) 0.3254 (5) 0.065 (3)
H15A 0.765606 0.987944 0.311425 0.078*
H15B 0.873351 0.873039 0.288437 0.078*
C16 0.9504 (16) 0.9263 (9) 0.3814 (6) 0.078 (3)
H16A 1.041210 0.984315 0.369420 0.117*
H16B 1.008665 0.850037 0.391787 0.117*
H16C 0.889185 0.955264 0.419306 0.117*

1 Source of materials

4-(Pyridin-2-yl)benzaldehyde (0.2200 g, 0.0012 mol) and K2PtCl4 (1.6602 g, 0.0004 mol) were suspended in 2-ethoxyethanol (100 g). Under nitrogen atmosphere, the suspension liquid was stirred at 80 °C for 12 h, 2-ethoxyethanol was removed by rotary evaporator, added diethylamine (5 g) and methanol (20 g) stirred at 50 °C for 10 h. The title crystals were obtained by slow evaporation from reaction solvent at room temperature.

2 Experimental details

Absorption corrections were used by using multi-scan program [1]. The structure was solved with Shelx [3, 4]. Hydrogen atoms were placed in their geometrically idealized positions. Hydrogen atoms were constrained to ride on their parent atoms.

3 Comment

Platinum compounds have been deeply studied in various fields and achieved good results, many have even been used in our lives. One-dimensional platinum-based nanostructures electrocatalysis an be effectively used in the field of new energy such as fuel cells due to their excellent oxygen reduction reaction (ORR) [5, 6]. In medicine, pembrolizumab plus pemetrexed and cisplatin or carboplatin complexes can effectively treat nonsquamous non-small-cell lung cancer, and can effectively improve the 5-year survival rate to 19.4 % [7]. Organic light-emitting diodes (OLEDs) optical device containing platinum complex as emissive layer can emit three primary colors of light efficiently, which occupied the mainstream position in various optical devices today [8]. The synthesis of Pt(II)complex is complicated and the product is not easy to purify. We synthesized the target complex by a one-pot reaction and the crystal was obtained by slow volatilization.

The title compound is a planar complex with platinum(II) as the central metal. The coordination sites of the compound was occupied by carbon, nitrogen and chlorine atoms respectively. The carbon atom is derived from the bidentate ligand 4-(pyridin-2-yl)benzaldehyde, the nitrogen atoms are derived from 4-(pyridin-2-yl)benzaldehyde and diethylamine, the chlorine atom is derived from K2PtCl4.

The distances of Pt1–Cl1 bonds are 2.4250(19) Å, the distances of Pt–N1 bonds are 2.032(6) Å, the distances of Pt1–N2 bonds are 2.082(6) Å, The distances of Pt1–C7 bonds are 1.971(7) Å, in addition, the C9–Pt1–N2 angle is 80.27(14)°. the N1–Pt1–Cl1 angle is 94.15(16)°, the N1–Pt1–N2 angle is 175.8(2)°, the N2–Pt1–Cl1 angle is 89.78(18)°, the C7–Pt1–Cl1 angle is 175.6(2)°, the C7–Pt1–N1 angle is 82.1(2)°, the C7–Pt1–N2 angle is 94.1(3)°. All bond lengths and bond angles fall within the normal range [9].

In the columns, two π⋯π interactions between adjacent aromatic rings are present. All the π⋯π interactions in the range of 3.647(4)–3.897(4) Å, all the dihedral angles are 0.6(4)° [10]. Also the crystal packing is consolidated by weak hydrogen bond interactions. The hydrogen bond is C8–H8⋯O1, the distance of C8–H8 bond is 0.93 Å, the distance of H8⋯O1 bond is 2.56 Å, the angle of C8–H8⋯O1 is 170° [11].


Corresponding author: Weixi Xue, Department of Chemistry, Newcastle University School of Natural and Environmental Sciences, Newcastle upon Tyne, Tyne & Wear, NE1 7RU, UK, E-mail:

  1. Author contributions: The author has accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Competing interests: The author declares no conflicts of interest regarding this article.

References

1. Bruker. Apex2, Saint and Sadabs; Bruker AXS Inc.: Madison, Wisconsin, USA, 2009.Suche in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Isabel, U., Sheldrick, G. M. An introduction to experimental phasing of macromolecules illustrated by SHELX; new autotracing features. Acta Crystallogr. 2018, D74, 106–116.10.1107/S2059798317015121Suche in Google Scholar PubMed PubMed Central

5. Huiting, N., Chenfeng, X., Lei, H., Shahid, Z., Thandavarayan, M., Wei, G., Bo, Y., Bao Yu, X. Rational design and synthesis of one-dimensional platinum-based nanostructures for oxygen-reduction electrocatalysis. Chin. J. Catal. 2022, 43, 1459–1472; https://doi.org/10.1016/s1872-2067(21)63862-7.Suche in Google Scholar

6. Erkin, N., Sander, R., Yurii, P. I., Matija, G., Luka, P., Can Ruüstü, Y., Peter, W., Giorgio, D., Nejc, H., Ivar, K. Sustainable CO2-derived nanoscale carbon support to a platinum catalyst for oxygen reduction reaction. ACS Appl. Nano Mater. 2023, 6, 5772–5780; https://doi.org/10.1021/acsanm.3c00208.Suche in Google Scholar

7. Marina, C. G., Shirish, G., Giovanna, S., Enriqueta, F., Emilio, E., Manuel, D., Maximilian, J. H., Steven, F. P., Helge, G. B., Nir, P., Francesco, G., Ross, R. J., Martin, R., Rina, H., Edward, B. G., Takayasu, K., Jhanelle, E. G., Paul, S., Erin, J., Catherine, M. P., Delvys, R. Pembrolizumab plus pemetrexed and platinum in nonsquamous non-small-cell lung cancer: 5-Year outcomes from the phase 3 KEYNOTE-189 study. J. Clin. Oncol. 2023, 41, 1992–1998; https://doi.org/10.1200/jco.22.01989.Suche in Google Scholar PubMed PubMed Central

8. Gloria, H., Xuemin, G., Céline, L., Zhen, Z., Jasmin, S., Jasmin, M. B., Stefan, B. A brief history of OLEDs-emitter development and industry milestones. Adv. Mater. 2021, 33, 2005630; https://doi.org/10.1002/adma.202005630.Suche in Google Scholar PubMed

9. Felix, W., Sergej, S., Joshua Immanuel, K., Thomas, S. Synthesis and photophysical properties of monometallic C^C* platinum(II) formamidinate complexes using Sterically demanding ligands. Angew. Chem. Int. Ed. 2023, 62, e202301225.10.1002/anie.202301225Suche in Google Scholar PubMed

10. Dai, Z., Kai, T., Ziyan, F., Aiping, X. Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol C24H19N3O. Z. Kristallogr. N. Cryst. Struct. 2023, 238, 1153–1155; https://doi.org/10.1515/ncrs-2023-0372.Suche in Google Scholar

11. Miao-Chang, L., Xiao-Bo, H., Deng-Ze, W. The crystal structure of 6-(benzofuran-2-yl)-2-oxo-4,5-diphenyl-3,4-dihydro-2H-pyran-3-carbonitrile, C26H17NO3. Z. Kristallogr. N. Cryst. Struct. 2024, 239, 255–256; https://doi.org/10.1515/ncrs-2023%E2%80%930512.10.1515/ncrs-2023-0512Suche in Google Scholar

Received: 2024-01-22
Accepted: 2024-03-01
Published Online: 2024-03-27
Published in Print: 2024-06-25

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of tris((Z)-2-hydroxy-N-((E)-pyridin-2-ylmethylene)benzohydrazonato-k2O,N)europium(III), C39H30N9O6Eu
  4. Crystal structure of (E)-3-(benzylideneamino)-2-phenylthiazolidin-4-one, C16H14N2OS
  5. The crystal structure of (E)-4-fluoro-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H15FN2O
  6. Crystal structure of (6-chloropyridin-3-yl)methyl 2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
  7. Crystal structure of methyl 3-methoxy-4-(2-methoxy-2-oxoethoxy)benzoate, C12H14O6
  8. The crystal structure of bis[(4-methoxyphenyl)(picolinoyl)amido-κ2 N:N′]copper(II), C26H22CuN4O4
  9. The crystal structure of poly[di(μ2-aqua)-diaqua-bis(3-aminopyridine-4-carboxylate-κ2 O: O′)-tetra(μ2-3-aminopyridine-4-carboxylate-κ2 O: O′)-dineodymium(III), [Nd2(C6H5N2O2)6(H2O)4] n
  10. The crystal structure of t-butyl 7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate, C28H34FNO4
  11. Crystal structure of catena-poly[(benzylamine-κ1 N)-(sorbato-κ1 O)-(μ2-sorbato-κ2 O,O′)-copper(II), C19H23CuNO4
  12. Crystal structure of (4-(2-chlorophenyl)-1H-pyrrol-3-yl)(ferrocenyl) methanone, C21H16ClFeNO
  13. The crystal structure of N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C19H17BrN2O2S2
  14. The crystal structure of N′-{5-[2-(2,6-dimethylphenoxy) acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide hydrate
  15. Crystal structure of 2-(naphthalen-1-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C26H24O3
  16. Crystal structure of naphthalen-1-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C25H22O3
  17. Crystal structure of poly[diaqua- (μ4-5-(1H-1,2,4-triazol-1-yl)benzene-1,3-dicarboxylato-κ5N:O,O’:O’’:O’’’)calcium(II), C10H9CaN3O6
  18. Crystal structure of (E)-N′-(4-((E)-3-(dimethylamino)acryloyl)-3-hydroxyphenyl)-N, N-dimethylformimidamide, C14H19N3O2
  19. Crystal structure of (E)-3-(dimethylamino)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one, C13H17NO4
  20. Crystal structure of (2-chloropyridin-3-yl)methyl-2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
  21. The crystal structure of diethyl 4-(3,4-dimethylphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C21H27NO4
  22. Crystal structure of (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H42O2
  23. Synthesis and crystal structure of 4-(4-cyclopropylnaphthalen-1-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C15H13N3S
  24. Crystal structure of catena-poly[aqua-(2,6-di-(2-pyridyl)-pyridine-κ3 N,N′, N″)(μ2-1,4-naphthalene dicarboxylato-κ2 O,O′)nickel(II)], C27H19NiN3O5
  25. Crystal structure of 3-(diphenylphosphoryl)-3-hydroxy-1-phenylpropan-1-one, C21H19O3P
  26. The crystal structure of R,S-{N-[(2-oxidonaphthalen-1-yl)methylidene]phenylglycinato}divinylsilicon, C23H19NO3Si
  27. The crystal structure of 1,2,4-tris(bromomethyl)benzene, C9H9Br3
  28. Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt
  29. Crystal structure of 3-(methoxycarbonyl)-1-(4-methoxyphenyl)-2,3,4,9- tetrahydro-1H-pyrido[3,4-b]indol-2-ium chloride hydrate, C40H48Cl2N4O9
  30. The crystal structure of 1-(2-chlorobenzyl)-3-(3-chlorophenyl)urea, C14H12Cl2N2O
  31. Hydrothermal synthesis and crystal structure of aqua-tris(4-acetamidobenzoato-κ2 O,O′)-(1,10-phenanthroline-κ2 N,N′)terbium(III) hydrate C39H36N5O11Tb
  32. The crystal structure of zwitterionic 3-aminoisonicotinic acid, C6H6N2O2
  33. The crystal structure of bis{[monoaqua-μ2-4-[(pyridine-4-carbonyl)-amino]-phthalato-κ3 N:O,O′-(2,2′-bipyridine κ2 N,N′)copper(II)]}decahydrate, C48H56N8O22Cu2
  34. Crystal structure of poly[μ10-4,4′-methylene-bis(oxy)benzoatodipotassium], C15H10K2O6
  35. The crystal structure of catena-poly[[tetraaqua[(μ2-1,4-di(4-methyl-1-imidazolyl)benzene] cobalt(II)]bis(formate)], C16H24CoN4O8
  36. The crystal structure of (E)-2-chloro-5-((2-(nitromethylene)imidazolidin-1-yl)methyl)pyridine, C10H11ClN4O2
  37. The crystal structure of (E)-1-(((2-amino-4,5-dimethylphenyl)iminio)methyl)naphthalen-2-olate, C19H18N2O
  38. Crystal structure of N-(acridin-9-yl)-2-(4-methylpiperidin-1-yl) acetamide monohydrate, C21H25N3O2
  39. The crystal structure of dichlorido-bis(3-methyl-3-imidazolium-1-ylpropionato-κ2 O,O′)-zinc(II), C14H20Cl2N4O4Zn
  40. The crystal structure of 2,8-diethyl-1,3,7,9-tetramethyl-4λ4,5λ4-spiro[dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine-5,2′-naphtho[1,8-de][1,3,2]dioxaborinine], C25H29BN2O2
  41. The crystal structure of 5-tert-butyl-2-(5-tert-butyl-3-iodo-benzofuran-2-yl)-3-iodobenzofuran, C24H24I2O2
  42. Synthesis and crystal structure of methyl 2-{[4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazole-3-yl]thio} acetate, C18H17N3O2S
  43. The crystal structure of n-propylammonium bis(2,3-dimethylbutane-2,3-diolato)borate-boric acid (1/1), [C3H10N][C12H24BO4]·B(OH)3
  44. Crystal structure of methyl 1-(2-bromophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C19H17BrN2O2
  45. Crystal structure of (4-bromobenzyl)triphenylphosphonium bromide ethanol solvate, C52H48Br4OP2
  46. The crystal structure of unsymmetrical BOPHY C26H27BN4
  47. The crystal structure of Tb3B5O11(OH)2
  48. The crystal structure of (Z)-4-ethyl-2-((4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3,5-dimethyl-2H-pyrrol-1-ium 2,2'-spirobi[naphtho[1,8-de][1,3,2]dioxaborinin]-2-uide, C37H37BN2O4
  49. Crystal structure of bis(methylammonium) hexadecaselenidopalladate(II), (CH3NH3)2PdSe16
  50. The crystal structure of (2-diphenylphosphanylphenyl) 2-[7-(dimethylamino)-2-oxochromen-4-yl]acetate, C31H26NO4P
  51. Crystal structure of (E)-6-(4-ethylpiperazin-1-yl)-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C23H25FN2O
  52. The structure of RUB-56, (C6H16N)8 [Si32O64(OH)8]·32 H2O, a hydrous layer silicate (2D-zeolite) that contains microporous levyne-type silicate layers
  53. Crystal structure of 4-amino-3,5-dibromobenzonitrile, C7H4Br2N2
  54. Crystal structure of 2-(naphthalen-1-yl)ethyl 2-acetoxybenzoate, C21H18O4
  55. Single-crystal structure determination of Tm3B12O19(OH)7
  56. Crystal structure determination of NdB3.6O7
  57. The crystal structure of NdB6O8(OH)5·H3BO3
  58. Crystal structure of 2-(5-ethylpyridin-2-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H25NO3
  59. Crystal structure of N-(1-(3,4-dimethoxyphenyl)-2-methylpropyl)aniline, C18H23NO2
  60. Crystal structure of Ba6Cd12Mn4SiF48
  61. Synthesis and crystal structure of 5-fluoro-1-methyl-2-oxo-3-(2-oxochroman-4-yl)indolin-3-yl acetate, C20H16FNO5
  62. The crystal structure of 6-methacryloylbenzo[d][1,3]dioxol-5-yl 4-nitrobenzenesulfonate, C17H13NO8S
  63. Crystal structure of ethyl 2-(3-benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)- 2,2-difluoroacetate, C19H16F2N2O3
  64. The crystal structure of tetrakis(μ 2-(1H-benzimidazole-2-methoxo-κ2 N,O:O:O)-(n-butanol-κO)-chlorido)-tetranickel(II), C48H68Cl4N8O8Ni4
  65. Synthesis and crystal structure of trans-tetraaqua-bis((1-((7-hydroxy-3-(4-methoxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carbonyl)oxy-κO)zinc(II)hexahydrate, C46H64N2O28S2Zn
  66. The crystal structure of 1-(4-carboxybutyl)-3-methyl-1H-imidazol-3-ium hexafluoridophosphate, C9H15F6N2O2P
  67. Crystal structure of 1-(4-chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O3
  68. Crystal structure of dimethyl (R)-2-(3-(1-phenylethyl)thioureido)-[1,1′-biphenyl]-4,4′-dicarboxylate, C25H24N2O4S
  69. The crystal structure of 1-(3-carboxypropyl)-1H-imidazole-3-oxide, C7H10N2O3
  70. Synthesis and crystal structure of dimethyl 4,4′-(propane-1,3-diylbis(oxy))dibenzoate, C19H20O6
  71. Crystal structure of methyl-1-(p-tolyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C20H20N2O2
  72. The crystal structure of 1-(1-adamantan-1-yl)ethyl-3-(3-methoxyphenyl)thiourea, C20H28N2OS
  73. The crystal structure of N,N′-carbonylbis(2,6-difluorobenzamide), C15H8F4N2O3
Heruntergeladen am 30.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2024-0033/html
Button zum nach oben scrollen